JPS63296770A - Subcutaneous embedding type reservoir - Google Patents
Subcutaneous embedding type reservoirInfo
- Publication number
- JPS63296770A JPS63296770A JP62134417A JP13441787A JPS63296770A JP S63296770 A JPS63296770 A JP S63296770A JP 62134417 A JP62134417 A JP 62134417A JP 13441787 A JP13441787 A JP 13441787A JP S63296770 A JPS63296770 A JP S63296770A
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- plate
- reservoir
- main body
- reservoir main
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000007920 subcutaneous administration Methods 0.000 title claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 19
- 230000002265 prevention Effects 0.000 claims description 9
- 230000009969 flowable effect Effects 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 abstract description 12
- 229940041181 antineoplastic drug Drugs 0.000 abstract description 12
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 230000000994 depressogenic effect Effects 0.000 abstract 4
- 229920001971 elastomer Polymers 0.000 abstract 2
- 239000000806 elastomer Substances 0.000 abstract 2
- 238000005553 drilling Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 239000004945 silicone rubber Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000002302 brachial artery Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 229920003146 methacrylic ester copolymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000003270 subclavian artery Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001042 thoracic artery Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【発明の詳細な説明】
本発明は、進行癌患者の化学療法における抗癌剤動脈内
注入に用いる皮下埋め込み式リザーバーの改良に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to improvements in subcutaneous implantable reservoirs used for intra-arterial injection of anticancer drugs in chemotherapy for advanced cancer patients.
(1)従来の技術及びその問題点
癌の治療の目的で、進行癌患者の動脈内に抗癌剤を注入
するための手段として、カテーテルを動脈内に挿入し留
置する方法による場合、抗癌剤注入口として該カテーテ
ルの末端を体外に露出させるときは、その露出部の清潔
維持に医療上多くの問題があった。例えば患者の入浴時
にその露出部の清潔を保つことが極めて困難であるなど
の問題を生じ、患者の日常生活に大きな障害となってい
る。また、治療上も薬剤注入に際し、無菌的に操作する
ため煩雑な手順を要することや露出部からの怒染、さら
にはその破損による出血の可能性などがこのカテーテル
留置法自体を煩わしいものとしている。これらのことが
進行癌患者の残された期間における社会復帰、或いは外
来治療を行う上での大きな妨げとなっている。(1) Conventional technology and its problems For the purpose of cancer treatment, when a catheter is inserted into the artery and left in place as a means for injecting an anticancer drug into the artery of a patient with advanced cancer, it is used as an anticancer drug inlet. When the distal end of the catheter is exposed outside the body, there are many medical problems in keeping the exposed portion clean. For example, problems arise such as it is extremely difficult to keep the exposed area clean when the patient takes a bath, and this poses a major hindrance to the patient's daily life. In addition, from a therapeutic perspective, this catheter placement method itself is troublesome, as it requires complicated procedures to operate aseptically, and there is a possibility of staining from the exposed area and bleeding due to damage. . These are major obstacles for patients with advanced cancer to return to society or receive outpatient treatment during their remaining years.
その問題を解決するため、動脈内に留置するカテーテル
の末端を体外に露出することなく患者の皮膚下に前記カ
テーテルの末端と連結するりザーバーを埋め込むものと
し、これに経皮的に抗癌剤を注入貯留させ、該抗癌剤を
適当量つづりザーバーからカテーテルへ流出するように
構成する手段が提案されているが、抗癌剤はその性質上
人体の組織を侵すものであるからカテーテル外へ薬剤が
漏出することは絶対に回避されなければならない。従来
のりザーバーはその漏出を完全に防ぐ手段を欠いていた
。In order to solve this problem, a reservoir was implanted under the patient's skin that connected to the end of the catheter, without exposing the end of the catheter to the outside of the body, and an anticancer drug was injected percutaneously into this reservoir. A method has been proposed in which the anticancer drug is stored in an appropriate amount and flows out from the reservoir into the catheter.However, since anticancer drugs by their nature attack the tissues of the human body, leakage of the drug to the outside of the catheter is unlikely. Must be avoided at all costs. Conventional glue reservoirs lacked means to completely prevent leakage.
(2)問題点を解決する技術手段
本発明は、その解決手段として、該リザーバーは針を反
復穿通しても薬剤が絶対漏出しないように、穿通を行な
う部分に板状体と流動性のない軟質の弾性体を交互に配
して成る漏出防止材を配設するようにした皮下埋め込み
式リザーバーを提案するものである。(2) Technical means to solve the problem The present invention provides a solution to the problem, in which the reservoir has a plate-like material and a non-fluid material in the part where the needle is penetrated, so that the drug will never leak out even if the needle is repeatedly penetrated. The present invention proposes a subcutaneously implantable reservoir in which a leakage prevention material made of alternating soft elastic bodies is provided.
該漏出防止材は、反復して行われる穿刺による抗癌剤の
漏出防止のため、抜針後に復元力のある材質であるだけ
では足りず、漏出防止材そのものがリザーバーからカテ
ーテルを経て血管に流入することが患者の生命に重大な
障害となるので、このようなことが絶対生じないもので
なければならない。そこで、本考案は、漏出防止材とし
て流動性のある材質のものを用いることを避け、上記問
題を解決した。In order to prevent leakage of the anticancer drug due to repeated punctures, the leakage prevention material must not only be made of a material that has resilience after the needle is removed, but also must be made of a material that has resilience after the needle is removed; the leakage prevention material itself must flow from the reservoir into the blood vessel via the catheter. Since this poses a serious threat to the patient's life, this must never occur. Therefore, the present invention solves the above problem by avoiding the use of a fluid material as the leakage prevention material.
(3)実施例
この発明の実施例を図を用いて説明すると第1図は、第
2図(平面図) A−A’線断面図で、リザーバー本体
2は上部に凹陥部3を下部に凹陥部6をそれぞれ穿設し
、凹陥部3には板状体4と流動性のない軟質の弾性体5
とを交互に配して成る漏出防止材を嵌入してリザーバー
本体2の上部に11を固着する一方凹陥部6には板状体
7を嵌着して抗癌剤を貯留する室を形成させ、リザーバ
ー本体2の下部に底板8を固着させ、前記凹陥部6の1
壁部に孔9を穿通し、これに第3図に示すように弁10
を有するカテーテル11が嵌着されている0Ml、リザ
ーバー本体2、底板8及びカテーテル11は生体への適
用を良好とするためシリコーンゴムを用い、板状体7は
抗癌剤注入に用いる針が容易に貫通しない材質であれば
よいが、前記漏出防止材は復元力があり、かつリザーバ
ー外へ流出しない材質とする。即ち、流動性のない軟質
の弾性体5とは、1)シリコーンパテ、2)感温軟化性
物質(例えば、ポリ酢酸ビニール、アクリル酸エステル
共重合体、メタアクリル酸エステル共重合体など)3)
含水軟化性物質(例えば、ポリビニールアルコールなど
)が良く、これと交互に配される板状体4は、ショアー
Aで50乃至70のシリコーンゴムを用いて形成する。(3) Embodiment An embodiment of the present invention will be explained with reference to the drawings. Fig. 1 is a sectional view taken along the line A-A' of Fig. 2 (plan view). A recessed portion 6 is formed in each recessed portion 3, and a plate-like member 4 and a non-flowable soft elastic member 5 are provided in each recessed portion 3.
11 is fixed to the upper part of the reservoir body 2 by inserting a leakage prevention material consisting of alternating layers, and a plate-like member 7 is fitted into the recessed part 6 to form a chamber for storing the anticancer drug. A bottom plate 8 is fixed to the lower part of the main body 2, and one of the recessed portions 6 is
A hole 9 is drilled through the wall, into which a valve 10 is inserted as shown in FIG.
The reservoir body 2, the bottom plate 8, and the catheter 11 are made of silicone rubber in order to be easily applied to living bodies, and the plate-like body 7 is made of silicone rubber so that a needle used for injecting anticancer drugs can easily penetrate it. The leakage prevention material should be made of a material that has a restoring force and does not leak out of the reservoir. That is, the non-flowable soft elastic body 5 includes 1) silicone putty, 2) a temperature-sensitive softening substance (for example, polyvinyl acetate, acrylic ester copolymer, methacrylic ester copolymer, etc.) 3 )
A water-containing softening material (for example, polyvinyl alcohol, etc.) is preferable, and the plate-shaped members 4 arranged alternately with this material are formed using Shore A silicone rubber of 50 to 70.
第4図は、板状体4と軟質の弾性体5を交互に配した1
例を示したものである。FIG. 4 shows a structure in which plate-like bodies 4 and soft elastic bodies 5 are arranged alternately.
This is an example.
なお、弁10は薬剤の逆流を防ぐ一方弁とする。Note that the valve 10 is a one-way valve that prevents backflow of the drug.
(4)使用方法
動脈に留置するカテーテルの挿入は、例えば左側胸動脈
、深大腿動脈、上腕動脈、鎖骨下動脈などを経由して行
い、該カテーテル外記リザーバー本体2に固着されたカ
テーテル11に嵌入して結紮し、リザーバーを、働者の
皮膚下に埋め込む手術を行う。薬剤の注入は同図の如く
穿刺して行う。(4) How to use A catheter to be placed in an artery is inserted through, for example, the left thoracic artery, deep femoral artery, brachial artery, subclavian artery, etc., and the catheter 11 fixed to the catheter reservoir body 2 is A surgical procedure is performed in which the tube is inserted, ligated, and the reservoir is implanted under the worker's skin. The drug is injected by puncturing as shown in the figure.
(5)本考案の効果 この発明は、次のような特別の効果を有する。(5) Effects of this invention This invention has the following special effects.
(ア)抗癌剤の注入にあたり、穿刺部位を除き無菌的防
禦の必要を小ならしめる。(a) When injecting anticancer drugs, reduce the need for aseptic protection, except for the puncture site.
(イ)薬剤の注入が容易で、かつその反復継続を可能と
する。(b) The drug can be easily injected and can be repeated repeatedly.
(つ)リザーバーを極く小型にし、かつ軽量とすること
を可能とし、従って患者の日常生活を全く制約しない。(1) It is possible to make the reservoir extremely small and lightweight, so it does not restrict the patient's daily life at all.
(1)リザーバーの生体適合性を良くできる。(1) The biocompatibility of the reservoir can be improved.
(オ)薬剤の漏出を完全に回避できるから、これによる
被害を防ぐことができ、かつ漏出防止材自体の人体への
流出をも完全に防止でき、極めて安全である。(E) Since the leakage of chemicals can be completely avoided, damage caused by this can be prevented, and the leakage prevention material itself can also be completely prevented from leaking into the human body, making it extremely safe.
(力)カテーテル露出部の破損のようなトラブルを生じ
ないから安全である。(Force) It is safe because it does not cause problems such as damage to the catheter exposed part.
(キ)本発明は、他の療法に広く応用することもできる
。(g) The present invention can also be broadly applied to other therapies.
第1図は第2図A−A線断面図、第2図は平面図、第3
図はカテーテル11の模型図、第4図は漏出防止材の配
設の1例を示す説明図である。
1・・蓋 2・・リザーバー本体3・・凹陥
部 4・・板状体
5・・弾性体 6・・凹陥部
7・・板状体 8・・底板
9・・孔 10・・弁
11・・カテーテル
特許出願代理人弁理士小 川 修
第4図
く
4r!−
1やロ
ー 〜 f0Figure 1 is a sectional view taken along the line A-A in Figure 2, Figure 2 is a plan view, and Figure 3 is a sectional view taken along the line A-A in Figure 2.
The figure is a model diagram of the catheter 11, and FIG. 4 is an explanatory diagram showing an example of the arrangement of the leakage prevention material. 1. Lid 2. Reservoir main body 3. Concave portion 4. Plate body 5. Elastic body 6. Concave portion 7. Plate body 8. Bottom plate 9. Hole 10. Valve 11.・Catheter patent application agent Osamu Ogawa 4r! −1 or low ~ f0
Claims (1)
状体4と流動性のない軟質の弾性体5とを交互に配して
成る漏出防止材を嵌入して蓋1を固着する一方リザーバ
ー本体2の下部に穿たれた陥凹部6には板状体7を嵌着
して底板8を固着し、前記凹陥部6の1壁部に孔9を穿
通し、これに弁10を有するカテーテル11が嵌入固着
されて成ることを特徴とする皮下埋め込み式リザーバー1 A leakage prevention material consisting of plate-shaped bodies 4 and non-flowable soft elastic bodies 5 arranged alternately is fitted into the recessed part 3 bored in the upper part of the reservoir body 2, and the lid 1 is fixed thereto. A plate-shaped body 7 is fitted into a recess 6 bored in the lower part of the reservoir body 2 to fix a bottom plate 8, and a hole 9 is bored through one wall of the recess 6, and a valve 10 is provided in the hole 9. A subcutaneous implantable reservoir characterized by a catheter 11 being inserted and fixed therein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62134417A JPS63296770A (en) | 1987-05-29 | 1987-05-29 | Subcutaneous embedding type reservoir |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62134417A JPS63296770A (en) | 1987-05-29 | 1987-05-29 | Subcutaneous embedding type reservoir |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63296770A true JPS63296770A (en) | 1988-12-02 |
JPH0331473B2 JPH0331473B2 (en) | 1991-05-07 |
Family
ID=15127898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62134417A Granted JPS63296770A (en) | 1987-05-29 | 1987-05-29 | Subcutaneous embedding type reservoir |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63296770A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0279955U (en) * | 1988-12-07 | 1990-06-20 | ||
JPH02309313A (en) * | 1989-05-25 | 1990-12-25 | Machida Seisakusho:Kk | Ring-shaped light projecting device |
JPH0367661U (en) * | 1989-11-08 | 1991-07-02 | ||
JPH0576450U (en) * | 1992-03-27 | 1993-10-19 | 住友ベークライト株式会社 | Chemical injection port |
JP2012045139A (en) * | 2010-08-26 | 2012-03-08 | Nihon Covidien Kk | Subcutaneous implantable port and method of manufacturing the same |
-
1987
- 1987-05-29 JP JP62134417A patent/JPS63296770A/en active Granted
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0279955U (en) * | 1988-12-07 | 1990-06-20 | ||
JPH063612Y2 (en) * | 1988-12-07 | 1994-02-02 | 住友ベークライト株式会社 | Chemical injection boat |
JPH02309313A (en) * | 1989-05-25 | 1990-12-25 | Machida Seisakusho:Kk | Ring-shaped light projecting device |
JPH0367661U (en) * | 1989-11-08 | 1991-07-02 | ||
JPH063613Y2 (en) * | 1989-11-08 | 1994-02-02 | 株式会社八光電機製作所 | Implantable reservoir |
JPH0576450U (en) * | 1992-03-27 | 1993-10-19 | 住友ベークライト株式会社 | Chemical injection port |
JP2012045139A (en) * | 2010-08-26 | 2012-03-08 | Nihon Covidien Kk | Subcutaneous implantable port and method of manufacturing the same |
Also Published As
Publication number | Publication date |
---|---|
JPH0331473B2 (en) | 1991-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5620419A (en) | Port stabilizer ring | |
US5944688A (en) | Implantable hemodialysis access port assembly | |
JP2888990B2 (en) | Implantable access device | |
US4781695A (en) | Implantable fluid dispenser | |
US3640269A (en) | Fluid-conducting instrument insertable in living organisms | |
US5997524A (en) | Catheter assembly for percutaneous access to subcutaneous port | |
US6929631B1 (en) | Method and apparatus for percutaneously accessing a pressure activated implanted port | |
JPS60114254A (en) | Automatic sealing subcataneous syringe site | |
JP2002159576A (en) | Liquid injection needle and liquid injector | |
EP2286849A1 (en) | Implantable vascular access | |
GB2459101A (en) | Subcutaneous port and catheter | |
KR20180037216A (en) | Drilling system | |
JPS63296770A (en) | Subcutaneous embedding type reservoir | |
US20070073239A1 (en) | Catheter device | |
JP3137360B2 (en) | Chemical injection port | |
CN111588940A (en) | Implanted infusion port and using method | |
KR200320341Y1 (en) | IV catheter for flowing backward prevention of blood | |
CN2275454Y (en) | Arteriovenous needle | |
JPS61234870A (en) | Skin embedding type reservoir | |
CN212651171U (en) | Implanted transfusion port | |
JPH0331305Y2 (en) | ||
RU205446U1 (en) | Subcutaneous implantable port | |
CN216725412U (en) | Transfusion port | |
JPH06277298A (en) | Embedded medicine liquid injection port | |
CN215460909U (en) | Implantable drug delivery device |